Chronic Illness CSR News

Ventec Life Systems and GM Partner to Mass Produce Critical Care Ventilators in Response to COVID-19 Pandemic

GM to also produce surgical masks to support frontline healthcare professionals
Press Release

BOTHELL, Wash., March 27, 2020 /3BL Media/ – Ventec Life Systems announced today General Motors will build VOCSN critical care ventilators at GM’s Kokomo, Indiana manufacturing facility with FDA-cleared ventilators scheduled to ship as soon as next month. This effort is in addition to Ventec taking aggressive steps to ramp up production at their manufacturing facility in Bothell, Washington.

Now More Than Ever, the Importance of Second Chances at Life

Press Release

As an international non-profit organization, every day DKMS provides 20 lifesaving blood stem cell transplants for blood cancer and blood disorder patients all around the world. Even in the current situation that we are facing with COVID-19, these patients still urgently need our help.

Gilead Sciences Statement on Ensuring Continued Supply of HIV Medicine Amid Coronavirus Outbreak

Press Release

FOSTER CITY, Calif., March 25, 2020 /3BL Media/ – For those with potentially immunosuppressing conditions, such as HIV, the uncertainty caused by the novel coronavirus pandemic can be particularly challenging. Gilead remains focused on ensuring that people living with or at risk for HIV have access to the medications and support needed.

IWBI Assembles Task Force on Role Buildings Can Play in Reducing Health Burden of COVID-19 and other Respiratory Infections

Summary: 

Former RWJF President and CEO Dr. Risa Lavizzo-Mourey, UCLA’s Dr. Jonathan Fielding, 17th Surgeon General of the United States Richard Carmona, Harvard School of Public Health’s Joseph Allen to co-chair the effort to advance the role of buildings in protecting and enhancing health.

Press Release

Former RWJF President and CEO Dr. Risa Lavizzo-Mourey, UCLA’s Dr. Jonathan Fielding, 17th Surgeon General of the United States Richard Carmona, Harvard School of Public Health’s Joseph Allen to co-chair the effort to advance the role of buildings in protecting and enhancing health.

COVID-19: How Companies Are Responding

Newsletter

As the COVID-19 pandemic continues to evolve on a daily and almost hourly basis, it is an “all-hands-on-deck” situation to mitigate the health crisis that requires government, nonprofits, business and individual citizens to act and support. As we all seek to better understand how companies can be a positive force during uncertain times, we’ve rounded up a few examples of companies stepping up to support coronavirus mitigation:

Profiles in Creating Possible: Julie Di Paolo is on a Mission to Understand Rheumatoid Arthritis and Other Inflammatory Diseases

Blog

When Julie Di Paolo’s father was diagnosed with Crohn’s disease, an inflammatory condition with limited treatment options, it sparked curiosity and drive that have carried forward into her career at Gilead, where she is Executive Director of Inflammation Biology.

“I realized how few medications were being developed to treat the drivers of inflammatory diseases, and how far away the field was from delivering curative therapy,” she recalls. “That still sticks with me today.”

Bill & Melinda Gates Foundation, Wellcome and Mastercard Launch Initiative to Speed Development and Access to Therapies for COVID-19

COVID-19 Therapeutics Accelerator will coordinate R&D efforts and remove barriers to drug development and scale-up to address the epidemic
Press Release

SEATTLE, March 10, 2020 /3BL Media/ – The Bill & Melinda Gates Foundation, Wellcome and Mastercard today committed up to $125 million in seed funding to speed-up the response to the COVID-19 epidemic by identifying, assessing, developing, and scaling-up treatments. The partners are committed to equitable access, including making products available and affordable in low-resource settings.

Perseverance in Rare Diseases at Sanofi

Summary: 

There are 7,000 known rare diseases in the world that collectively affect 350 million patients. For these patients and their families, the journey can be long and challenging. 

Sanofi has pledged to help improve the care, the health and the lives of people affected by a rare disease for nearly 40 years. Even when a therapy has been proven to work, Sanofi continues to find ways to do more to advance patient care and improve quality of life. Its approach is simple and rooted in perseverance–one family at a time.

Article

There are 7,000 known rare diseases in the world that collectively affect 350 million patients. For these patients and their families, the journey can be long and challenging. 

Sanofi has pledged to help improve the care, the health and the lives of people affected by a rare disease for nearly 40 years. Even when a therapy has been proven to work, Sanofi continues to find ways to do more to advance patient care and improve quality of life. Its approach is simple and rooted in perseverance–one family at a time.

Alexion Announces Launch of Alexion Charitable Foundation and Calls for Grantees

Ahead of Rare Disease Day, new support becomes available to the rare community
Press Release

BOSTON, February 27, 2020- /3BL Media/ - Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced the launch of the Alexion Charitable Foundation to provide further suppo

Pages

Subscribe to Chronic Illness